First Time Loading...

ReShape Lifesciences Inc
NASDAQ:RSLS

Watchlist Manager
ReShape Lifesciences Inc Logo
ReShape Lifesciences Inc
NASDAQ:RSLS
Watchlist
Price: 0.1677 USD -4.17% Market Closed
Updated: May 10, 2024

Gross Margin
ReShape Lifesciences Inc

63.9%
Current
59%
Average
47%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
63.9%
=
Gross Profit
5.5m
/
Revenue
8.7m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
US
ReShape Lifesciences Inc
NASDAQ:RSLS
3.9m USD
64%
US
Abbott Laboratories
NYSE:ABT
182B USD
55%
US
Intuitive Surgical Inc
NASDAQ:ISRG
136.7B USD
66%
US
Stryker Corp
NYSE:SYK
126B USD
64%
IE
Medtronic PLC
NYSE:MDT
109.7B USD
66%
US
Boston Scientific Corp
NYSE:BSX
108.6B USD
69%
US
Becton Dickinson and Co
NYSE:BDX
68B USD
41%
DE
Siemens Healthineers AG
XETRA:SHL
58.5B EUR
36%
US
Edwards Lifesciences Corp
NYSE:EW
52.7B USD
77%
US
Dexcom Inc
NASDAQ:DXCM
50.8B USD
63%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
367.2B CNY
65%
ReShape Lifesciences Inc
NASDAQ:RSLS
Country US
Market Cap 3.9m USD
Gross Margin
64%
Abbott Laboratories
NYSE:ABT
Country US
Market Cap 182B USD
Gross Margin
55%
Intuitive Surgical Inc
NASDAQ:ISRG
Country US
Market Cap 136.7B USD
Gross Margin
66%
Stryker Corp
NYSE:SYK
Country US
Market Cap 126B USD
Gross Margin
64%
Medtronic PLC
NYSE:MDT
Country IE
Market Cap 109.7B USD
Gross Margin
66%
Boston Scientific Corp
NYSE:BSX
Country US
Market Cap 108.6B USD
Gross Margin
69%
Becton Dickinson and Co
NYSE:BDX
Country US
Market Cap 68B USD
Gross Margin
41%
Siemens Healthineers AG
XETRA:SHL
Country DE
Market Cap 58.5B EUR
Gross Margin
36%
Edwards Lifesciences Corp
NYSE:EW
Country US
Market Cap 52.7B USD
Gross Margin
77%
Dexcom Inc
NASDAQ:DXCM
Country US
Market Cap 50.8B USD
Gross Margin
63%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Country CN
Market Cap 367.2B CNY
Gross Margin
65%

Profitability Report

View the profitability report to see the full profitability analysis for ReShape Lifesciences Inc.

Full Profitability Report

See Also

Summary
RSLS intrinsic value, competitors valuation, and company profile.
DCF Valuation
RSLS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RSLS stock valuation using valuation multiples.
Wall Street Estimates
RSLS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RSLS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
63.9%
=
Gross Profit
5.5m
/
Revenue
8.7m
What is the Gross Margin of ReShape Lifesciences Inc?

Based on ReShape Lifesciences Inc's most recent financial statements, the company has Gross Margin of 63.9%.

ALPHA SPREAD
Join more than 135,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.